Get software! [General Sta­tis­tics]

posted by verstc – China, 2018-06-17 14:55 (1512 d 13:22 ago) – Posting: # 18910
Views: 4,783

Dear Helmut,

Thanks a lot for your reply.

It is clear to me for your explain.

I am wondering if there is a way to reduce the intra-subject CV. I think intra-subject CV is an inherent characteristic of a drug. is it right? If it not, does anyone can reduce it by any ways?

Thanks,

best,
Shawn


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,288 posts in 4,665 threads, 1,583 registered users;
online 8 (0 registered, 8 guests [including 5 identified bots]).
Forum time: Monday 04:18 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5